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Highligths 
 MBGs containing small amounts of Ga, Ce or Zn exhibit high in vitro bioactivity 
 The bioactive response is preserved after obtaining 3D scaffolds 
 These scaffolds are optimum candidates for bone tissue engineering applications 
 MBG scaffold with 4% ZnO exhibit bactericide action against S. Aureus 
 The effects of the extra ions is sometimes complex and needs to be investigated                                                                                                                                                                                                                                                                                                                                                                                                               
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Abstract 
 3D scaffolds based in mesoporous bioactive glasses (MBGs) are being widely investigated to 
use in bone tissue engineering (TE) applications. These scaffolds are often obtained by rapid 
prototyping (RP) and exhibit an array of interconnected pores in a hierarchy of sizes. The 
ordered mesopores network (around 4 nm in diameter), is optimal for the adsorption and release 
of bone inductor biomolecules, and the arrangement of macropores over 100 m facilitates the 
bone cell ingrowths and angiogenesis. Nevertheless MBGs composition can be varied almost 
infinitely at the atomic scale by including in the glass network oxides of inorganic elements 
with a therapeutic action. In this article the synthesis and characterization of MBG scaffolds 
based on the 80%SiO2–15%CaO–5%P2O5 (in mol-%) glass with substitutions up to 3.5% of 
Ga2O3 or Ce2O3 or 7.0% of ZnO is revisited. The substituent inclusion and the RP processing 
slightly decrease the surface area, the pore volume and the mesoporous order as well as their 
bioactive response in solutions mimicking blood plasma. However, these values still remain 
useful for bone TE applications. Results exhibiting the bactericide action of MBG scaffolds 
containing ZnO are also presented. 
 
Keywords 
Mesoporous bioactive glass scaffolds; Ga, Ce and Zn as therapeutical ions; bactericide 
capability; bone tissue engineering  
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1. Introduction 
Recently bioactive glasses have been widely investigated for diverse clinical applications 
including the tissue engineering (TE) of bone. Several families can be distinguished in 
the historical evolution of the bioactive glass investigation, beginning with the first Melt 
Prepared Glasses (MPGs), discovered by Hench et al in 1969 [1], followed by the 
bioactive Sol-Gel Glasses (SGGs) also proposed also by Hench in 1991 [2] and the most 
recent, glasses with ordered mesoporosity designed by Zhao and Vallet-Regi, who 
investigated independently and reported them for the first time in 2004 and 2006 [3,4]. 
These glasses denoted as Mesoporous Bioactive Glasses (MBGs) are the main subject of 
this article. 
Simultaneous to the development of glasses with characteristics more and more 
adapted for use as implant materials, there was a change in the paradigm of the role of 
bioactive materials used in Orthopedics and Dentistry. In the past, there was a search for 
materials for the simple substitution and repair of osseous tissues. In 2002 Hench and 
Polack proposed the search of materials aimed to drive and favor the regeneration of bone, 
denoted as third generation biomaterials [5].  In their studies they demonstrated that the 
silicon and calcium ions released from bioactive melt glasses as granules stimulated the 
genes to persuade the cells to form bone. 
The so-called third generation biomaterials can be directly classified in the field 
of the TE of bone. The first generation are as bioinert as possible and the bioactive or 
resorbable biomaterials are considered the second generation. It is well known that TE is 
based on three fundamental pillars: cells, signal molecules and scaffolds [6]. This last 
pillar, where the MBGs are processed into 3D scaffolds, is considered as an optimal 
option. An important requirement is that these scaffolds exhibit an interconnected and 
hierarchical porosity, that is to say, with several orders of magnitude including giant pores 
(channels) and macropores that allow internal angiogenesis and the interaction with cells. 
Nevertheless, pores of nanometric size are also required like those exhibited by the 
mesoporous materials. Such pores allow the inclusion of signal molecules that induce the 
formation of bone like the Bone Morphogenetic Proteins (BMPs), growth factors like 
Vascular Endothelial Growth Factor (VEGF), or different fractions of Parathyroid 
Hormone related Peptide (PTHrP) [7]. 
With all these ideas in mind, in the last few years CaO–P2O5–SiO2 based MBG 
scaffolds (MBG_Sc) are been widely investigated as optimum candidates for bone TE 
applications. Effectively all these features have special characteristics for the role they 
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must play when implanted for the regeneration of osseous tissues. First, the ordered 
mesoporosity allows the adsorption and release in a controlled manner of the bone 
induction agents previously mentioned. In addition, these mesoporous channels confer 
extremely high values of surface area and pore volume to MBGs which increase the 
already high levels of bioactivity of CaO–P2O5–SiO2 glasses obtained by the quenching 
of a melt or by sol-gel processing [8,9]. Keeping in mind the essential properties of a 3D 
scaffold for bone TE applications, several strategies have been proposed for the design of 
a macroporosity required for cell functions such as the bone cells ingrowths, the nutrients 
supply and vascularization, as well as for the adhesion and development of the bone cells.  
These strategies include foaming, freeze drying, fiber bonding or rapid prototyping (RP) 
technologies [10]. Obviously, in all cases it is very important to confirm that the MBGs 
powder processing to obtain the scaffolds does not destroy the ordered mesoporosity and 
bioactivity.  
On the other hand, because MBGs are glasses they do not exhibit an exact 
composition and can be substituted with small amounts of extra oxides of cations 
featuring important biological actions, such as osteogenesis, antibacterial capacity, 
angiogenesis or cementogenesis [11–13]. For this reason, there is a general trend to 
upgrade properties with some of the well known therapeutical ions because of their 
biological action [14–16]. Figure 1 depicts an approximate time required for in vitro 
bioactivity for the three families of bioactive glasses and the year of discovering of each 
family. The biological action of inorganic ions used for upgrade the glasses are also 
included.  
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Figure 1. Left: timeline in the discovering of the three families of bioactive glasses and the 
approximate time required for a standard member of each family was coated by an apatite-like 
layer after being soaked in a simulated body fluid. Right: some ions investigated to upgrade the 
glasses and their biological effects. 
The three families of bioactive glasses showed on the Figure 1 are silicate-based 
glasses, with the presence of CaO as essential requirement for bioactivity. The third 
component use to be P2O5 which binds calcium producing calcium phosphate nuclei that 
completely modifies the reactivity of glasses when contact with biological fluids [17].  
The development of the three families of glasses was together with an increase of the 
textural properties (surface area and pore volume) in going from the dense MPGs to the 
MBGs exhibiting over 500 m2/g of surface area and more than 0.5 cm3/g of pore volume. 
The surface area and porosity of MBGs are practically half of the values for pure silica 
mesoporous materials such as MCM-41 or SBA-15, but they are more than twofold the 
values of sol-gel glasses with analogous composition [18]. Noticeably such increase of 
textural properties produces an increase in the kinetics of the bioactive response. 
However, such increase is not significant in terms of the bone of formation induced by 
these glasses. More important is the new capabilities in terms of the ability to include and 
release of biologically active substances in the MBGs pores. 
Regarding the biological effect of the extra inorganic ions included in the glasses, 
osteogenesis   was the first feature investigated for bone TE applications. For this reason 
some of the most important property searched for the extra elements added to upgrade the 
SiO2–CaO–P2O5 glasses was an osteogenic character. In addition, one of the main 
problems when a material is implanted in bone is osteomyelitis caused for bacterial 
infection. Thus, a second important property investigated was the ability of fight against 
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infection. For this reason elements with antibacterial ability have been also investigated. 
Because a biomedical application of bioactive glasses is Dentistry, inorganic ions with 
cementogenic properties were also investigated. Finally to fulfill some of the mentioned 
properties is necessary the formation of blood vessels that feed to the cells. Consequently 
the addition of angiogenic elements is reaching also a great interest.   
 The main objective of this paper to review the state of the art and perspectives of 
future of MBG scaffolds based on the 15%CaO–5%P2O5–80%SiO2 glass enriched with 
extra ions to add extra features when implanted that made the more beneficial for the role 
the will must fulfill when be implanted for the regeneration of the bone tissue. In 
particular our group has been very interested in the last few years in the substitution of 
MBGs by (i) up to 3.5% Ce2O3, because it was reported that Ce
3+ ions reduce the enamel 
demineralization, and are neuroprotective [19], (ii) up to 3.5% Ga2O3, because it was 
published that Ga3+ ions increase the calcium content in bone, and are antimicrobial [20], 
and (iii) ZnO because, in addition to other biological functions, it was reported that Zn2+ 
ions stimulates the bone formation and exhibit also a bactericide action [21,22]. In the 
Figure 2 are depicted the role of every one of the elements of the MBG_Sc essential to 
play their role in bone TE. The biological actions of Ce3+, Ga3+ and Zn2+ ions, that are the 
main objective of this paper, is highlighted in the Figure.  
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Figure 2. Features that convert MBG scaffolds in optimum candidates for bone TE are 
summarized. The extra properties that could come for the addition of the inorganic ions revisited 
in this paper are highlighted.   
2. Mesoporosity, textural properties and bioactivity of substituted MBG powders 
SiO2–CaO–P2O5–X (X= Ce2O3, Ga2O3 or ZnO) MBG powders are synthesized by the 
evaporation induced self-assembly (EISA) method [23]. As reactants are generally used 
tetraethyl orthosilicate, triethyl phosphate, calcium nitrate tetrahydrate and cerium, 
gallium or zinc nitrates that are dissolved in ethanol and adding nitric acid as catalyst and 
Pluronic® P123 as surfactant [24]. The sol obtained is poured in a Petri dish for the solvent 
evaporation. Resultant materials are thermally treated for the surfactant and nitrates 
removal to obtain MBG powders. Other approach for the synthesis of MBGs can be found 
in ref [25].   
Figure 3 shows some results obtained after characterization of MBG powders 
with compositions obtained by substituting the 15%CaO–5%P2O5–80%SiO2 (in mol-%) 
glass  with  amounts of Ce2O3, Ga2O3 up to 3.5% and  ZnO up to 7.0%. In Fig. 3a it can 
be observed maxima in the Low Angle X ray Diffraction (LA-XRD) patterns, indicative 
of mesoporous ordered arrangements. MBGs lack long distance structural order because 
they are glasses and do not exhibit diffraction maxima in the Wide Angle XRD patterns 
(WA-XRD). If we observe the LA-XRD pattern correspondent to unsubstituted glass 
(thereafter will be denoted as blank, B), a sharp maximum at 1.4 º in 2, that can be 
indexed to the (10) reflection of a 2D hexagonal-phase is observed. This maximum is less 
defined when the Ce2O3 content in the MBG increased but is still present in the sample 
containing 3.5%  Ce2O3 which is indicative that the ordered arrangements of mesoporous 
is maintained in all cases. Analogous results were obtained for the Ga2O3 and ZnO 
containing MBGs mot included here by the shake of brevity. 
As an example, in the Figure 3b the N2 adsorption isotherms of two Cerium-doped 
MBGs (0.2% and 3.5%) and their corresponding pore size distributions are showed. The 
curves are identified as type IV isotherms characteristic or mesoporous materials with 
Type H1 hysteresis loops characteristic of cylindrical pores open at both ends. Figure 3c 
summarizes relevant properties from N2 adsorption obtained for the three series of 
samples investigated. As it can be observed the surface area and the pore volume for these 
MBG powders decrease from a BET surface area of 515 m2/g and pore volume of 0.58 
cm3/g for the unsubstituted MBG, until values in all cases superior to 300 m2/g and 0.27 
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cm3/g, i.e. still higher to those of glasses obtained by conventional sol-gel method. 
Moreover, Figures 3d and 3e correspond respectively to the Scanning Electron 
Microscopy (SEM) images and the Energy Dispersive X-ray Spectroscopy (EDS) 
spectrum of the 0.2% Ce2O3 containing MBG. The EDS spectrum confirms the presence 
of cerium in the glass and values of the other glass components very close to the nominal 
ones. 
 
Figure 3. Physical-chemical characterization of MBG powders based on the 15%CaO-5%P2O5-80%SiO2 
composition substituted by amounts up to 3.5 mol-%  of Ce2O3  or Ga2O3 and 7 % mol-% of ZnO, before 
(a, b, c, d and e) and after be soaked by one day in SBF (f and g). (Results from ref. 24) 
Because their composition and the excellent textural properties, it would be 
expected a good enough in vitro bioactive for these doped MBGs.  Thus, Figures 3f and 
3g correspond to the 0.2% Ce2O3 MBG after being soaked by 1day in a Simulated Body 
Fluid (SBF) at 37ºC proposed by Kokubo et al [26]. These Figures probes the quick in 
vitro bioactive response of these samples because even after only one day of treatment 
the surface of the glass particles appear coated by the cauliflower-type particles 
characteristic of an hydroxycarbonate apatite layer (HCA) which presence use to be 
indicative of the in vitro bioactive behavior of an investigated material  [27]. The 
correspondent EDS spectrum indicates that the layer is mainly composed by calcium and 
phosphorous and the study by Fourier Transformed Infrared (FTIR) Spectroscopy not 
shown also allows detecting the presence of the characteristic bands of phosphate in a 
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crystalline environment. This quick in vitro bioactive response, in terms of the formation 
of the HCA layer was exhibited by all the scaffolds containing Ce2O3 and Ga2O3. 
However in the case of the ZnO-substituted MBGs the presence of Zn2+ ions modified 
the HCA formation process hindering the formation of the HCA layer.  
In summary, at the levels of substitution with Ce3+, Ga3+ and Zn2+ ions 
investigated, the glass powders maintain mesoporosity and a quick in vitro bioactive 
response. However, some differences in the in vitro bioactivity kinetic were observed as 
a function of the composition. For these properties MBG including Cerium, Galium or 
Zinc are good candidates for bone TE applications. For this application the capacity of 
the scaffolds to load and release biomolecules in a controlled way was investigated. In 
our first attempt our group select Curcumin as a model drug [28]. The MBG powders 
showed capability to release the drug although a strong interaction between the drug and 
the added elements such as Ga3+ ions was observed. Evidently this ion was added to 
upgrade the MBGs but they interacted with Curcumin molecules increasing the load 
capacity but decreasing also the release process. In this way, for 3.5% Ga2O3 the drug 
remained into the mesopores without being able to be released to the surrounding 
medium. 
3. Textural properties and bioactivity of substituted MBG scaffolds 
 
Figure 4. Physical-chemical characterization of 3D scaffolds based on the 15%CaO-5%P2O5-80%SiO2 
MBG substituted by amounts below 1mol-%  of Ce2O3  or Ga2O3 and 2% mol-% of ZnO, before (a, b, c, d, 
e and f) and after be soaked 1 day in SBF (h, i and j). (Results from ref. 28) 
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Different conformation methods can be used to obtain MBG scaffolds (MBG_Sc) 
including porogens, electrospinning, supercritical processing or freeze-drying from 
suspensions using replicas of porous sponges. In our studies rapid prototyping (RP) 3D 
printing was used because it allows the processing of scaffolds with complex geometries 
and fine structures with a control of porosity [29]. MBG powders are milled and sieved 
to obtain grains below 32 m that are suspended in dichloromethane. This suspension is 
added to a solution of polycaprolactone in dichloromethane and the mixture allowed to 
evaporate until a paste with the appropriate consistency for injection is formed. The paste 
is introduced into a polyethylene injection cartridge of an EnvisionTEC GmbH 3-D 
Bioplotter™ printing device to obtain pieces that are dried at 70 ºC and calcined at 500 
ºC to obtain the MBG_Scs. 
The hierarchical porosity of the scaffolds implies certain sacrifice of their 
mechanical properties which limits the clinical uses of the constructs formed by a 
bioceramic scaffold decorated with signal molecules and cells. However several authors 
have added specific elements to the MBG_Sc to improve its mechanical properties. For 
instance, Zhang et al has recently reported the synthesis of Sr-containing scaffolds with 
uniform interconnected macropores and high porosity which exhibit a compressive 
strength around 170 times that of polyurethane foam template MBG scaffolds [30]. This 
can be a good strategy to increase the mechanical properties because other attempts of 
our group as the increase of the heating temperature slightly increased the mechanical 
properties but with a severe decrease of the in vitro bioactive response (unpublished 
results).  
Figure 4 depicts some results of the physical chemical characterization of MBG 
scaffolds with compositions obtained by substituting the 15%CaO–5%P2O5–80%SiO2 (in 
mol-%) glass with up to 1.0 % of Ce2O3 or Ga2O3 or up to 2.0% of ZnO. Figures 4a, b, c, 
d, e, and f correspond to the untreated scaffolds, whereas Figs 4h, i and j, corresponds to 
MBG_Sc after being soaked for 1 day in SBF, in order to evaluate their in vitro bioactive 
response.  
LA-XRD patterns of Figure 4a show that the ordered mesoporous arrangement is 
well maintained in Blank scaffold and also in that doped with 0.2% Ga2O3. However, in 
the 1% Ga2O3 scaffold the manipulations necessary to obtain the scaffolds by rapid 
prototyping [28] i. e. grinding, obtaining a paste, 3D printing layer by layer and heating 
to eliminate the polymer; greatly deteriorate the mesoporous order, as it is indicated for 
the presence only of a shoulder in the LA-XRD pattern. As it was determinate by 
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Transmission Electron Microscopy (TEM), results not shown, in these scaffolds a worm-
like order of mesoporous was observed. However, for the scaffold with 2.0% ZnO, a clear 
maximum in the LA-XRD pattern in was present.  
Fig. 4b depicts N2 adsorption isotherms of two Gallium containing MBG_Sc. The 
characteristics of these curves are the same than those of the MBG powders already 
described in the previous section. In Figure 4c the most significant values of the textural 
properties are indicated. If we compare the SBET of Blank MBG powder, 515 m
2/g, with 
that of Blank MBG_Sc that is 398 m2/g and the lower of the doped MBG_Sc that is 344 
m2/g, we confirm that these looses are acceptable if compared with the biological benefits 
that suppose the obtaining of 3D scaffolds and the inclusion of therapeutic metallic 
elements. As it can be observed in Fig 4c, the pore volume and pore diameter also 
experience tolerable decreases.  
 Figures 4d, e and f, correspond to the 1.0 % of Ga2O3 MBG_Sc untreated and 
Figures 4h, I and j to the same scaffold after be treated by one day in SBF. As it can be 
observed, after this treatment there are clear evidences that the glass was coated by an 
HCA layer indicative of a very quick bioactive response. 
 Therefore the scaffolds obtained with the doped MBG exhibit attractive textural 
properties as well as a bioactive behavior. Thus, the additional features theoretically 
introduced by the therapeutical metallic elements were investigated. The possible 
antibacterial capability of scaffolds enriched with Gallium and Zinc is analyzed in the 
next section.  
4. Antibacterial properties of ZnO containing MBG scaffolds 
An important possible application of these MBG scaffolds is the bactericide effect of 
specific cations such as Zn2+ or Ga3+. The interest in this case would be to check if the 
scaffolds were able to exhibit a clear antibacterial capability against one of the bacteria 
present in the most part of the prosthesis infections after surgery. Simultaneously it would 
be needed that the ions released to the medium does not convert in non biocompatible to 
these scaffolds. 
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Figure 5. Left: in vitro biocompatibility study in osteoblastic-like cells and right: in vitro antibacterial 
capacity against S. Aureus of 15%CaO-5%P2O5-80%SiO2 MBG scaffolds containing 4% mol-% of ZnO.  
(Results from  ref. 31) . 
In Figure 5 is shown the more important results obtained after the study of 
biocompatibility and antibacterial capacity of some MBG_Sc based on the glass 
15%CaO–5%P2O5–80%SiO2 doped with 4% of ZnO [31]. As it was indicated in the 
introduction, ZnO was included because it exhibits several positive biological effects 
including the antibacterial capability. Effectively the infection of prosthesis is one of the 
most important problems arising when a material is implanted into the body. This 
importance is going to increase in the future with the organization of the pathogens 
bacteria into biofilms resistant to many families of antibiotics. For this reason new 
imaginative approaches must be attempted and one of them can be the inclusion of 
elements with declared antibacterial capacity such as Zn2+ or Ga3+. It must be mentioned 
that the possible bactericide capacity of the inclusion of Ga2O3 was investigated but in 
this case the Ga3+ ions remains into the glass network without exhibit the sample 
antibacterial capability.  
As it can be in the Figure, the unsubstituted MBG_Sc,  i. e. Blank used as a control 
group exhibit certain antibacterial capability against S. Aureus because the Silicon and 
Calcium ions. However, the inclusion of 4% ZnO in the scaffolds drastically increased 
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the amount of S. Aureus dead compared with the control group. Nevertheless it is 
important to cheek if materials releasing so high amounts of Zn2+ ions remain to be 
biocompatible. On the right part of the figure it can be observes the osteoblast 
development investigated in both the well-base and in extracts of culture medium after 
the soaking f the Zn-loaded scaffolds for 1, 3 and 6 days. For substitutions as high as 7% 
ZnO (results not shown) the obtained material was not biocompatible indicating that the 
concentration of the extra elements is a critical point that must be considered.   
5. Conclusions 
The inclusion of therapeutically active metallic ions in MBGs and their processing by 
rapid prototyping in 3D scaffolds slightly decreases the textural properties (surface area 
and porosity) and the in vitro bioactive response in fluids mimicking human plasma. 
However these values are so high in the ternary CaO–P2O5–SiO2 MBGs that they remain 
high enough to allow for the use of ion-substituted MBG scaffolds in bone TE 
applications. MBGs are excellent materials to employ as the base for the 3D scaffolds 
because of their inherent ordered mesoporosity which is not destroyed during the 
scaffolds processing nor during the inclusion of therapeutical elements. Thus, this 
material can be loaded with biomolecules that exert a synergic effect with the metallic 
ions.  
6. Future perspectives 
3D scaffold based on CaO–P2O5–SiO2 MBGs enriched with metallic oxides of 
elements with biological significance is a promising subject for bone TE. The resultant 
materials exhibit more than acceptable textural properties and vitro bioactivity. This plus 
the added value of substituent ions make them excellent candidates as scaffolds in bone 
TE.  
Results obtained show that much more work must be performed in this field 
because unexpected results are sometimes obtained. For instance, some ions such as Ga3+ 
actuate as intermediate ions between network formers and network modifiers. 
Furthermore, the acid of Lewis character of this cation also pushes it into the glass surface 
instead of being homogeneously distributed over the entire glass network. In this position 
there is a strong interaction with the basic Lewis centers of some of the possible 
substances to be adsorbed and released into the glasses mesopores. In fact, a higher 
interaction with the matrix will produce higher taxes of adsorption of the drug, but this 
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high interaction hinders the release of the adsorbed biomolecules making the use of this 
specific ion not useful at least at certain specific concentration levels.  
At the present Ga3+ ions are involved in new and very promising strategies to fight 
against infections that will not develop bacterial resistances as antibiotics or antimicrobial 
peptides do [32]. Ga3+ ions compete with Fe3+ ions uptake by the siderophores necessary 
for the bacteria biofilms survival [33].  
Other factors that must be taken into account are due to the high bioactivity of 
these materials. The quick formation of an HCA layer can hinder or slow down the 
liberation of the specific biomolecules included in the mesopores or even the release of 
the ions included with antibacterial or other purposes.     
On the other hand, it was recently reported the ability of Ce3+/Ce4+ containing 
bioactive glasses to inhibit oxidative stress by mimicking the catalase enzyme activity 
[34]. 
Consequently the inclusion of every specific inorganic ion in the MBG scaffolds, 
and even the specific concentration of the cation need to be deeply investigated before 
translated into clinical applications. 
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